{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:24:05Z","timestamp":1765545845794,"version":"3.40.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.10.060","type":"journal-article","created":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T08:55:15Z","timestamp":1383123315000},"page":"6155-6160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program"],"prefix":"10.1016","volume":"31","author":[{"given":"Takao","family":"Ozaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.10.060_bib0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0010","series-title":"Requirements for varicella vaccine (live). Requirements for biological substances No. 36","first-page":"102","author":"WHO experts committee on biological standardization","year":"1985"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0015","first-page":"35","article-title":"Application of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infection","volume":"18","author":"Asano","year":"1975","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(76)92397-7","article-title":"Use of live varicella vaccine in children with acute leukaemia or other malignancies","volume":"2","author":"Hattori","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0025","first-page":"69","article-title":"Use of a live varicella vaccine for acute leukemic children shortly after exposure in a children's ward","volume":"21","author":"Ozaki","year":"1978","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0030","first-page":"29","article-title":"Application of a live varicella vaccine to hospitalized children and its follow-up study","volume":"25","author":"Katsushima","year":"1982","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0035","first-page":"99","article-title":"Immunization of acute leukemic children with a live varicella vaccine (Oka strain)","volume":"27","author":"Kamiya","year":"1984","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0040","first-page":"39","article-title":"Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children","volume":"27","author":"Ozaki","year":"1984","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0045","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/S0264-410X(00)00016-5","article-title":"Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic","volume":"18","author":"Ozaki","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0050","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.vaccine.2004.08.040","article-title":"Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan","volume":"23","author":"Ozaki","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0055","first-page":"400","article-title":"Varicella vaccine","volume":"38","author":"Ozaki","year":"2010","journal-title":"Clin Virol"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0091-6749(97)70204-5","article-title":"Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines","volume":"100","author":"Kumagai","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0264-410X(99)00441-7","article-title":"Gelatin-containing diphtheria\u2013tetanus\u2013pertussis (DTP) vaccine causes sensitization to gelatin in the recipients","volume":"18","author":"Kumagai","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.11150\/kansenshogakuzasshi.86.146","article-title":"Utility of immune adherence hemagglutination method for antibody measurement of varicella vaccination","volume":"86","author":"Ozaki","year":"2012","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0075","first-page":"9","article-title":"The age distribution of neutralizing antibodies against varicella-zoster virus in healthy individuals","volume":"23","author":"Ozaki","year":"1980","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.11150\/kansenshogakuzasshi.85.161","article-title":"Varicella vaccine potency and stability during transport and delivery","volume":"85","author":"Kamiya","year":"2011","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.11150\/kansenshogakuzasshi.86.749","article-title":"A study for the necessity of virus titer of varicella vaccine presently used","volume":"86","author":"Ozaki","year":"2012","journal-title":"Kansenshogaku Zasshi"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2013.10.060_bib0090","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1093\/infdis\/174.Supplement_3.S310","article-title":"Varicella vaccine: the Japanese experience","volume":"174","author":"Asano","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1442-200X.1997.tb03664.x","article-title":"High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain)","volume":"39","author":"Takayama","year":"1997","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0100","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.1997.03550180045035","article-title":"Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center","volume":"278","author":"Izurieta","year":"1997","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0105","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00006454-199912000-00004","article-title":"Postlicensure study of varicella vaccine effectiveness in a day-care setting","volume":"18","author":"Clements","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0110","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"V\u00e1zquez","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/341089","article-title":"Younger age at vaccination may increase risk of varicella vaccine failure","volume":"186","author":"Galil","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/340868","article-title":"An outbreak of varicella among children attending preschool and elementary school in Illinois","volume":"35","author":"Dworkin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7883\/yoken.52.208","article-title":"Pediatric admission for vaccine preventable diseases: a 5-year survey from 1994 to 1998 in Aichi Prefecture","volume":"52","author":"Ozaki","year":"1999","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.11150\/kansenshogakuzasshi1970.80.212","article-title":"Cost-effectiveness analysis of routine immunization for varicella in Japan","volume":"80","author":"Sugawara","year":"2006","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0135","first-page":"1157","article-title":"National and state vaccination coverage among children aged 19\u201335 months \u2013 United States, 2010","volume":"60","author":"CDC","year":"2011","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0140","series-title":"Fact sheet about varicella vaccine. July 7","first-page":"7","author":"National Institute of Infectious Diseases","year":"2010"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0145","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.11150\/kansenshogakuzasshi.87.409","article-title":"Immunogenicity of additional varicella vaccination 3\u20135 years after the initial vaccination","volume":"87","author":"Ozaki","year":"2013","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S0950268809990860","article-title":"Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia","volume":"138","author":"Gao","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/infdis\/jiq081","article-title":"Impact of 2-dose vaccination on varicella epidemiology: Connecticut \u2013 2005\u20132008","volume":"203","author":"Kattan","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0170","first-page":"1416","article-title":"Efficacy and safety of co-administration of live attenuated varicella vaccine and measles-rubella (MR) vaccine","volume":"117","author":"Ohashi","year":"2013","journal-title":"J Jpn Pediatr Soc"},{"key":"10.1016\/j.vaccine.2013.10.060_bib0175","series-title":"Vaccines","first-page":"1395","article-title":"Community immunity","author":"Fine","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13014539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13014539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T18:57:38Z","timestamp":1746039458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13014539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":35,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0264410X13014539"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}